IWMvsPPH
iShares Russell 2000 ETF against VanEck Pharmaceutical ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IWM | PPH | |
|---|---|---|
| Expense ratio | 0.19% | 0.36% |
| Assets | $79.3B | $1B |
| Net flow, 1 month | +$2.1B | +$17M |
| Net flow, 1 year | −$1.3B | +$303M |
| Return, YTD | +12.8% | +6.1% |
| Return, 1 year | +13.7% | +17.2% |
| Avg daily volume | 24.6M | 291K |
| Holdings | 1941 | 27 |
| Listed | May 22, 2000 | Feb 1, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS